Literature DB >> 27706715

Effects of MMP-1 and MMP-3 gene polymorphisms on gene expression and protein level in lumbar disc herniation.

B Eser1, O Eser2, Y Yuksel3, H Aksit4, E Karavelioglu5, M Tosun3, Z Sekerci6.   

Abstract

The aim of this study was to identify the possible correlation between polymorphisms in matrix metalloproteinase (MMP)-1 and MMP-3 and their corresponding protein levels in disc tissues obtained from patients with lumbar disc herniation (LDH) using biochemical and immunohistochemical analyses. Blood and disc samples were obtained from 100 patients with LDH who underwent a lumbar microdiscectomy. Based on the radiological degeneration, the patients were diagnosed with grade 2, 3, or 4 LDH. MMP-1 -1607 1G/2G and MMP-3 -1171 5A/6A were analyzed by real-time polymerase chain reaction. The expressions of MMP-1 and MMP- 3 were detected by biochemical and immunohistochemical analyses. We found no association between the MMP-1 polymorphism and disc degeneration and MMP-1 expression. However, patients expressing the 6A/6A and 5A/6A alleles of MMP-3 -11715A/6A showed higher MMP-3 expression, compared to those expressing the 5A/5A genotype. Additionally, the radiological degeneration grades were correlated with the histological degeneration scoring. Protein levels and immunopositive cell rates of MMP-1 and MMP-3 were associated with disc degeneration grades. Moreover, the MMP-1 and MMP-3 expression and the histological and radiological scores were positively correlated and the MMP-3 -11715A/6A polymorphism was associated with MMP-3 expression in herniated disc tissues. This study is the first to investigate polymorphisms in MMP-1 and MMP-3, as well as their corresponding protein expressions. We also quantified an association between the radiological degeneration grades and MMP-1 and MMP- 3 expression. Further genomic studies on MMPs could focus on the utilization of MMP-1 and MMP-3 as markers for the prevention and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27706715     DOI: 10.4238/gmr.15038669

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

1.  Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.

Authors:  Soumaya Boumiza; Sarra Bchir; Hela Ben Nasr; Ammar Abbassi; Marie-Paule Jacob; Xavier Norel; Zouhair Tabka; Karim Chahed
Journal:  Dis Markers       Date:  2017-11-26       Impact factor: 3.434

2.  Variants of ACAN are associated with severity of lumbar disc herniation in patients with chronic low back pain.

Authors:  Romain Shanil Perera; Poruwalage Harsha Dissanayake; Upul Senarath; Lalith Sirimevan Wijayaratne; Aranjan Lional Karunanayake; Vajira Harshadeva Weerabaddana Dissanayake
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

Review 3.  Genetic background of degenerative disc disease in the lumbar spine.

Authors:  Yoshiharu Kawaguchi
Journal:  Spine Surg Relat Res       Date:  2018-02-28

4.  Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study.

Authors:  Nicola Fiotti; Filippo Mearelli; Filippo Giorgio Di Girolamo; Luigi Mario Castello; Alessio Nunnari; Salvatore Di Somma; Enrico Lupia; Efrem Colonetti; Maria Lorenza Muiesan; Giuseppe Montrucchio; Carlo Giansante; Gian Carlo Avanzi; Gianni Biolo
Journal:  Biomolecules       Date:  2022-02-09

Review 5.  Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration.

Authors:  Md Entaz Bahar; Jin Seok Hwang; Mahmoud Ahmed; Trang Huyen Lai; Trang Minh Pham; Omar Elashkar; Kazi-Marjahan Akter; Dong-Hee Kim; Jinsung Yang; Deok Ryong Kim
Journal:  Antioxidants (Basel)       Date:  2022-08-14

6.  Interactions between the MMP-3 gene rs591058 polymorphism and occupational risk factors contribute to the increased risk for lumbar disk herniation: A case-control study.

Authors:  Yongjun Luo; Jiaxing Wang; Jie Pei; Yuluo Rong; Wei Liu; Pengyu Tang; Weihua Cai; GuoYong Yin
Journal:  J Clin Lab Anal       Date:  2020-03-10       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.